Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit

Abstract

Anti-NF-L antibodies seem to be raised in progressive MS and may serve as a marker for axonal loss and disease progression. They may contribute to axonal loss and the accumulation of disability.